Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon–ribavirin‐based therapy-Reference-Cited by-同舟云学术

Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon–ribavirin‐based therapy

Published:2017-07-29 Issue:3 Volume:48 Page:
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Hayashi Kazuhiko¹^ORCID,Ishigami Masatoshi¹,Yasuda Satoshi¹,Ishizu Yoji¹,Kuzuya Teiji¹,Honda Takashi¹,Ishikawa Tetsuya¹,Hirooka Yoshiki¹,Goto Hidemi¹

Affiliation:

1. Department of Gastroenterology and Hepatology Nagoya University Graduate School of Medicine Nagoya Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hepr.12929

Reference33 articles.

1. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

3. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

4. Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection

5. Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into unexpected relapse and recovery in HCV-infected patients by studying a stochastic within-host HCV model;Applied Mathematics Letters;2024-03

2. Cryoglobulinemic Vasculitis Associated with Monoclonal Gammopathy of Undetermined Significance Developed after Sustained Virologic Response of Hepatitis C: A Case Report;Internal Medicine;2023

3. The risk of hepatitis C virus recurrence in hepatitis C virus‐infected patients treated with direct‐acting antivirals after achieving a sustained virological response: A comprehensive analysis;Liver International;2021-06-16

4. Induction of Profibrotic Microenvironment via TLR4 MyD88-Dependent and -Independent Inflammatory Signaling in Chronic Hepatitis C Virus Infection;Viral Immunology;2020-11-01

5. EVALUATION OF TREATMENT RESPONSE IN PATIENTS OF CHRONIC HEPATITIS 'C' VIRUS WITH RIBAVARIN THERAPY AND CONVENTIONAL INTERFERON AND TO KNOW THEIR THERAPEUTIC EFFECTS ON SUSTAINED VIRAL RESPONSE;INDO AM J PHARM SCI;2018